Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.

[1]  D. Pennell,et al.  Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction , 2017 .

[2]  Amit R. Patel,et al.  Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. , 2017, JACC. Cardiovascular imaging.

[3]  R. Chan,et al.  Prognostic Value of LGE-CMR in HCM: A Meta-Analysis. , 2016, JACC. Cardiovascular imaging.

[4]  D. Andreini,et al.  Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study. , 2016, Journal of the American College of Cardiology.

[5]  M. Mayr,et al.  Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment. , 2016, International journal of cardiology.

[6]  Hans Eiskjær,et al.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.

[7]  Amit R. Patel,et al.  Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. , 2016, International journal of cardiology.

[8]  M. Schwab,et al.  Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach , 2016, Journal of Cardiovascular Magnetic Resonance.

[9]  S. Prabhu,et al.  Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy , 2016, Journal of cardiovascular electrophysiology.

[10]  S. Grieve,et al.  Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study , 2016, Lupus.

[11]  Amit R. Patel,et al.  Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction , 2016, Circulation. Cardiovascular imaging.

[12]  Jonathan R. Weir-McCall,et al.  Left Ventricular Noncompaction Anatomical Phenotype or Distinct Cardiomyopathy ? , 2016 .

[13]  E. Nagel,et al.  T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure. , 2016, JACC. Cardiovascular imaging.

[14]  E. Nagel,et al.  T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. , 2015, Circulation. Cardiovascular imaging.

[15]  Pietro Delise,et al.  Right Ventricular Strain and Dyssynchrony Assessment in Arrhythmogenic Right Ventricular Cardiomyopathy: Cardiac Magnetic Resonance Feature-Tracking Study , 2015, Circulation. Cardiovascular imaging.

[16]  P. Kellman,et al.  Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2015, Circulation.

[17]  N. Geller,et al.  Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. , 2015, American heart journal.

[18]  C. Kramer.  Role of Cardiac MR Imaging in Cardiomyopathies , 2015, The Journal of Nuclear Medicine.

[19]  Barry J Maron,et al.  New perspectives on the prevalence of hypertrophic cardiomyopathy. , 2015, Journal of the American College of Cardiology.

[20]  B. Wong,et al.  Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy , 2015, Journal of the American Heart Association.

[21]  S. Piechnik,et al.  T1 mapping and survival in systemic light-chain amyloidosis , 2014, European heart journal.

[22]  D. Kaye,et al.  Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. , 2015, European heart journal cardiovascular Imaging.

[23]  S. K. White,et al.  Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance , 2014, Journal of Cardiovascular Magnetic Resonance.

[24]  G. Kitas,et al.  Heart failure imaging patterns in systemic lupus erythematosus. Evaluation using cardiovascular magnetic resonance. , 2014, International journal of cardiology.

[25]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[26]  E. Cook,et al.  Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.

[27]  René M. Botnar,et al.  Coronary Vessel Wall Contrast Enhancement Imaging as a Potential Direct Marker of Coronary Involvement , 2014, JACC. Cardiovascular imaging.

[28]  V. Fuster,et al.  The MOGE(S) classification of cardiomyopathy for clinicians. , 2014, Journal of the American College of Cardiology.

[29]  D. Bluemke,et al.  Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update , 2014, Journal of Cardiovascular Magnetic Resonance.

[30]  Amit R. Patel,et al.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.

[31]  Karima Addetia,et al.  Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. , 2014, The American journal of cardiology.

[32]  James A. White,et al.  CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. , 2014, JACC. Cardiovascular imaging.

[33]  S. K. White,et al.  Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.

[34]  Subha V Raman,et al.  Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. , 2014, American journal of respiratory and critical care medicine.

[35]  D. Pennell,et al.  Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy , 2014, Heart.

[36]  S. Raman,et al.  Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function , 2013, Journal of Cardiovascular Magnetic Resonance.

[37]  Amit R. Patel,et al.  Atrioventricular heart block and syncope coincident with diagnosis of systemic lupus erythematosus. , 2013, The Canadian journal of cardiology.

[38]  R. Kwong,et al.  Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients , 2013, Journal of Cardiovascular Magnetic Resonance.

[39]  Richard B. Thompson,et al.  T1 Mapping With Cardiovascular MRI Is Highly Sensitive for Fabry Disease Independent of Hypertrophy and Sex , 2013, Circulation. Cardiovascular imaging.

[40]  A. Freeman,et al.  Predictors of cardiac sarcoidosis using commonly available cardiac studies. , 2013, The American journal of cardiology.

[41]  R. Kwong,et al.  T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular imaging.

[42]  S. K. White,et al.  Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping , 2013, Circulation. Cardiovascular imaging.

[43]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[44]  Reza Razavi,et al.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.

[45]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[46]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[47]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[48]  A. Flett,et al.  Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis: An Equilibrium Contrast Cardiovascular Magnetic Resonance Study , 2013, Circulation. Cardiovascular imaging.

[49]  Stefan Neubauer,et al.  Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.

[50]  L. Mulligan,et al.  Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[51]  Igor Klem,et al.  Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation , 2011, Journal of the American College of Cardiology.

[52]  D. Bluemke,et al.  Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis , 2012, Journal of Cardiovascular Magnetic Resonance.

[53]  P. Sanders,et al.  Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. , 2012, European heart journal.

[54]  Amit R. Patel,et al.  Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study , 2011, European journal of heart failure.

[55]  Angelo Auricchio,et al.  Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[56]  M. Friedrich,et al.  Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. , 2011, JACC. Cardiovascular imaging.

[57]  P. Kistler,et al.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. , 2011, Journal of the American College of Cardiology.

[58]  P. Sanders,et al.  Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography , 2011, Journal of Cardiovascular Magnetic Resonance.

[59]  G. Aquaro,et al.  Myocardial fibrosis in isolated left ventricular non‐compaction and its relation to disease severity , 2011, European journal of heart failure.

[60]  D. Berman,et al.  Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. , 2011, JACC. Cardiovascular imaging.

[61]  Gilbert Habib,et al.  Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. , 2010, European heart journal.

[62]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[63]  S. Abbara,et al.  Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major , 2010 .

[64]  P. Kistler,et al.  Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients with Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death , 2010 .

[65]  R. Kim,et al.  Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.

[66]  J. Wansapura,et al.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. , 2009, Journal of the American College of Cardiology.

[67]  D J Pennell,et al.  Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major , 2009, Circulation.

[68]  D. Isenberg,et al.  Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus , 2008, Annals of the rheumatic diseases.

[69]  Matthew W. Darlison,et al.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[70]  S. Colan,et al.  Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. , 2008, JACC. Cardiovascular imaging.

[71]  Luigi Rega,et al.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[72]  R. Wassmuth,et al.  Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach , 2008, Lupus.

[73]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[74]  S. Neubauer,et al.  Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.

[75]  D. Knockaert.  Cardiac involvement in systemic inflammatory diseases. , 2007, European heart journal.

[76]  P. Elliott,et al.  Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa , 2007, Heart.

[77]  F. Saremi,et al.  Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis , 2007, The International Journal of Cardiovascular Imaging.

[78]  S. Caruthers,et al.  Occult Cardiac Contractile Dysfunction in Dystrophin-Deficient Children Revealed by Cardiac Magnetic Resonance Strain Imaging , 2005, Circulation.

[79]  H. Crijns,et al.  The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. , 2005, Chest.

[80]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[81]  R. Kim,et al.  Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.

[82]  Stefan Neubauer,et al.  Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[83]  W. Dassen,et al.  Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. , 2005, Journal of the American College of Cardiology.

[84]  P. Woodard,et al.  Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report , 2005, Lupus.

[85]  R. Falk,et al.  Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.

[86]  Hugh Calkins,et al.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[87]  Marvin D Nelson,et al.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. , 2004, Blood.

[88]  D. Pennell,et al.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. , 2003, European heart journal.

[89]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[90]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[91]  Kluwer Academic Publishers.  The international journal of cardiovascular imaging , 2001 .

[92]  Byun,et al.  Patients with Systemic Lupus Erythematosus , 1999 .

[93]  H. Hishida,et al.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. , 1999, American heart journal.

[94]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[95]  E. Nagel,et al.  Mapping in Discrimination of Hypertrophic Phenotypes : Hypertensive Heart Disease and Hypertrophic Cardiomyopathy Findings From the International T 1 Multicenter Cardiovascular Magnetic Resonance Study , 2022 .